Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00644592 · ClinicalTrials.gov registry record · NA
LXRA Gene Polymorphisms and Response to Fenofibrate
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00644592 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 11 participants.
The verdict
NCT00644592, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This is a research study of how a cholesterol medication known as fenofibrate works differently in people with different genetic backgrounds. "Genetics" refers to certain things that are passed to a person by their parents, such as eye color or hair color. Genetic differences lead to people having different eye and hair color. There are also genetic differences in a protein called liver X receptor-alpha (LXRA), which may be important in predicting the response to fenofibrate.
Interventions
- DRUG Fenofibrate
- DRUG Fenofibrate capsule daily for 4 weeks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00644592
The ClinicalTrials.gov registry entry for NCT00644592 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fenofibrate is the first listed.
NCT00644592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00644592 about?
NCT00644592 is a clinical study titled "LXRA Gene Polymorphisms and Response to Fenofibrate". This is a research study of how a cholesterol medication known as fenofibrate works differently in people with different genetic backgrounds. "Genetics" refers to certain things that are passed to a person by their parents, such as eye color or hair color. Genetic differences lead to people having d...
What is the current status of trial NCT00644592?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2008-03. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00644592?
The interventions under investigation include: Fenofibrate (DRUG), Fenofibrate capsule daily for 4 weeks (DRUG).
Who is sponsoring clinical trial NCT00644592?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.